{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:58:34Z","timestamp":1777517914257,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:00:00Z","timestamp":1636675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:00:00Z","timestamp":1636675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>With the increasing number of breast cancer (BC) diagnosed as a second primary malignancy after a first primary non-breast cancer (BCa-2), it is unclear about the familial risk of BC among women with a first-degree relative (FDR, parents or siblings) affected by a BCa-2.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this Swedish nationwide cohort study, 5315 women with a FDR affected by BCa-2 and 115,048 women with a FDR affected by BC as the first primary cancer (BCa-1) were followed for the first primary invasive BC diagnosis. Relative risk (RR) of BC was estimated through Poisson regression by using 2,743,777 women without a family history of cancer as reference. The risk was stratified by the diagnostic age of BC in FDR, proband type, the time interval between the first primary cancer and BCa-2 in FDR as well as the site of first primary cancer diagnosed in FDR before BCa-2. We also calculated the cumulative incidence of BC from birth to a specific age for the three groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The cumulative incidence from birth to age 70 was 10% among women with a family history of BCa-2. The RR of BC with a family history of BCa-2 (RR, 1.68, 95%CI, 1.49 to 1.88) was comparable to that with BCa-1 (1.68, 1.63 to 1.73). The risk was largely consistent irrespective of proband type. The age of onset of BCa-2 in FDR (RR<jats:sub>early-onset<\/jats:sub>, 1.72 vs. RR<jats:sub>late-onset<\/jats:sub>1.67) had less influence on the risk compared to BCa-1 in FDR (1.89 vs. 1.63). In the analysis stratified by the time between the first primary cancer and BCa-2 in relatives, the risks were largely similar. For the site of first primary cancer diagnosed in FDR before BCa-2, the increased BC risk was found in women whose FDRs were diagnosed with first primary gastric, colorectal, endometrial, ovarian, nervous system and endocrine gland cancers, and non-Hodgkin lymphoma.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Women with a family history of BCa-2 have a similar overall BC risk as those with a family history of BCa-1. The risk varied according to the site of first primary cancer diagnosed in FDR before BCa-2.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12885-021-08925-y","type":"journal-article","created":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T16:04:48Z","timestamp":1636733088000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Family history of breast cancer as a second primary malignancy in relatives: a nationwide cohort study"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4337-9017","authenticated-orcid":false,"given":"Guoqiao","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianguang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,12]]},"reference":[{"issue":"6","key":"8925_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"8925_CR2","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1002\/ijc.28510","volume":"134","author":"C Frank","year":"2014","unstructured":"Frank C, Fallah M, Ji J, Sundquist J, Hemminki K. The population impact of familial cancer, a major cause of cancer. Int J Cancer. 2014;134(8):1899\u2013906. https:\/\/doi.org\/10.1002\/ijc.28510.","journal-title":"Int J Cancer"},{"issue":"1","key":"8925_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep12891","volume":"5","author":"C Frank","year":"2015","unstructured":"Frank C, Fallah M, Sundquist J, Hemminki A, Hemminki K. Population landscape of familial cancer. Sci Rep. 2015;5(1):1\u20138. https:\/\/doi.org\/10.1038\/srep12891.","journal-title":"Sci Rep"},{"issue":"21","key":"8925_CR4","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1093\/jnci\/86.21.1600","volume":"86","author":"DE Goldgar","year":"1994","unstructured":"Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. JNCI: J Natl Cancer Inst. 1994;86(21):1600\u20138. https:\/\/doi.org\/10.1093\/jnci\/86.21.1600.","journal-title":"JNCI: J Natl Cancer Inst"},{"issue":"6","key":"8925_CR5","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.mcna.2020.08.003","volume":"104","author":"AK Narayan","year":"2020","unstructured":"Narayan AK, Lee CI, Lehman CD. Screening for breast cancer. Med Clin N Am. 2020;104(6):1007\u201321. https:\/\/doi.org\/10.1016\/j.mcna.2020.08.003.","journal-title":"Med Clin N Am"},{"issue":"1","key":"8925_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1001\/jamaoncol.2019.3876","volume":"6","author":"T Mukama","year":"2020","unstructured":"Mukama T, Kharazmi E, Xu X, Sundquist K, Sundquist J, Brenner H, et al. Risk-adapted starting age of screening for relatives of patients with breast cancer. JAMA Oncol. 2020;6(1):68\u201374. https:\/\/doi.org\/10.1001\/jamaoncol.2019.3876.","journal-title":"JAMA Oncol"},{"issue":"1","key":"8925_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12885-019-6452-0","volume":"20","author":"A Feller","year":"2020","unstructured":"Feller A, Matthes KL, Bordoni A, Bouchardy C, Bulliard J-L, Herrmann C, et al. The relative risk of second primary cancers in Switzerland: a population-based retrospective cohort study. BMC Cancer. 2020;20(1):51. https:\/\/doi.org\/10.1186\/s12885-019-6452-0.","journal-title":"BMC Cancer"},{"issue":"9","key":"8925_CR8","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1002\/ijc.27462","volume":"131","author":"J Ji","year":"2012","unstructured":"Ji J, Sundquist K, Sundquist J, Hemminki K. Comparability of cancer identification among death registry, cancer registry and hospital discharge registry. Int J Cancer. 2012;131(9):2085\u201393. https:\/\/doi.org\/10.1002\/ijc.27462.","journal-title":"Int J Cancer"},{"issue":"3","key":"8925_CR9","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1158\/0008-5472.CAN-06-3854","volume":"67","author":"K Hemminki","year":"2007","unstructured":"Hemminki K, Ji J, Forsti A. Risks for familial and contralateral breast cancer interact multiplicatively and cause a high risk. Cancer Res. 2007;67(3):868\u201370. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-3854.","journal-title":"Cancer Res"},{"issue":"5","key":"8925_CR10","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3109\/02841869709001300","volume":"36","author":"J-E Fr\u00f6din","year":"1997","unstructured":"Fr\u00f6din J-E, Ericsson J, Barlow L. Multiple primary malignant tumors in a national cancer registry: Reliability of reporting. Acta Oncol. 1997;36(5):465\u20139. https:\/\/doi.org\/10.3109\/02841869709001300.","journal-title":"Acta Oncol"},{"issue":"2","key":"8925_CR11","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/annonc\/mdi041","volume":"16","author":"J Lorenzo Bermejo","year":"2005","unstructured":"Lorenzo Bermejo J, Hemminki K. A population-based assessment of the clustering of breast cancer in families eligible for testing of BRCA1 and BRCA2 mutations. Ann Oncol. 2005;16(2):322\u20139. https:\/\/doi.org\/10.1093\/annonc\/mdi041.","journal-title":"Ann Oncol"},{"issue":"11","key":"8925_CR12","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1002\/ijc.30927","volume":"141","author":"G Zheng","year":"2017","unstructured":"Zheng G, Yu H, Hemminki A, F\u00f6rsti A, Sundquist K, Hemminki K. Familial associations of female breast cancer with other cancers. Int J Cancer. 2017;141(11):2253\u20139. https:\/\/doi.org\/10.1002\/ijc.30927.","journal-title":"Int J Cancer"},{"issue":"7","key":"8925_CR13","doi-asserted-by":"publisher","first-page":"e0201097","DOI":"10.1371\/journal.pone.0201097","volume":"13","author":"K Al-Ajmi","year":"2018","unstructured":"Al-Ajmi K, Lophatananon A, Ollier W, Muir KR. Risk of breast cancer in the UK biobank female cohort and its relationship to anthropometric and reproductive factors. PLoS One. 2018;13(7):e0201097. https:\/\/doi.org\/10.1371\/journal.pone.0201097.","journal-title":"PLoS One"},{"key":"8925_CR14","unstructured":"US Department of Health and Human Services. The health consequences of smoking: a report of the Surgeon General. 2004."},{"issue":"8","key":"8925_CR15","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1002\/ijc.28988","volume":"135","author":"C Cybulski","year":"2014","unstructured":"Cybulski C, Nazarali S, Narod SA. Multiple primary cancers as a guide to heritability. Int J Cancer. 2014;135(8):1756\u201363. https:\/\/doi.org\/10.1002\/ijc.28988.","journal-title":"Int J Cancer"},{"issue":"12","key":"8925_CR16","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1093\/annonc\/mdn527","volume":"19","author":"A Brandt","year":"2008","unstructured":"Brandt A, Bermejo JL, Sundquist J, Hemminki K. Age of onset in familial cancer. Ann Oncol. 2008;19(12):2084\u20138. https:\/\/doi.org\/10.1093\/annonc\/mdn527.","journal-title":"Ann Oncol"},{"issue":"4","key":"8925_CR17","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1200\/PO.19.00301","volume":"4","author":"KN Maxwell","year":"2020","unstructured":"Maxwell KN, Wenz BM, Kulkarni A, Wubbenhorst B, D\u2019Andrea K, Weathers B, et al. Mutation rates in cancer susceptibility genes in patients with breast Cancer with multiple primary cancers. JCO Precis Oncol. 2020;4(4):916\u201325. https:\/\/doi.org\/10.1200\/PO.19.00301.","journal-title":"JCO Precis Oncol"},{"issue":"6","key":"8925_CR18","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1053\/gast.2001.29611","volume":"121","author":"PD Pharoah","year":"2001","unstructured":"Pharoah PD, Guilford P, Caldas C, International Gastric Cancer Linkage Consortium. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology. 2001;121(6):1348\u201353. https:\/\/doi.org\/10.1053\/gast.2001.29611.","journal-title":"Gastroenterology"},{"issue":"12","key":"8925_CR19","doi-asserted-by":"publisher","first-page":"e83261","DOI":"10.1371\/journal.pone.0083261","volume":"8","author":"Z-Y Qi","year":"2013","unstructured":"Qi Z-Y, Shao C, Huang Y-L, Hui G-Z, Zhou Y-X, Wang Z. Reproductive and exogenous hormone factors in relation to risk of meningioma in women: a meta-analysis. PLoS One. 2013;8(12):e83261. https:\/\/doi.org\/10.1371\/journal.pone.0083261.","journal-title":"PLoS One"},{"issue":"1","key":"8925_CR20","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3892\/ol.2014.2144","volume":"8","author":"YJ Jeong","year":"2014","unstructured":"Jeong YJ, Oh HK, Bong JG. Multiple endocrine neoplasia type 1 associated with breast cancer: a case report and review of the literature. Oncol Lett. 2014;8(1):230\u20134. https:\/\/doi.org\/10.3892\/ol.2014.2144.","journal-title":"Oncol Lett"},{"issue":"6","key":"8925_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1080\/09553000902883836","volume":"85","author":"ES Gilbert","year":"2009","unstructured":"Gilbert ES. Ionising radiation and cancer risks: what have we learned from epidemiology. Int J Radiat Biol. 2009;85(6):467\u201382. https:\/\/doi.org\/10.1080\/09553000902883836.","journal-title":"Int J Radiat Biol"},{"issue":"2","key":"8925_CR22","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/ije\/dyy290","volume":"48","author":"IT Gram","year":"2019","unstructured":"Gram IT, Park S-Y, Maskarinec G, Wilkens LR, Haiman CA, Le Marchand L. Smoking and breast cancer risk by race\/ethnicity and oestrogen and progesterone receptor status: the multiethnic cohort (MEC) study. Int J Epidemiol. 2019;48(2):501\u201311. https:\/\/doi.org\/10.1093\/ije\/dyy290.","journal-title":"Int J Epidemiol"},{"issue":"6","key":"8925_CR23","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.mayocp.2020.04.017","volume":"95","author":"AH McClintock","year":"2020","unstructured":"McClintock AH, Golob AL, Laya MB. Breast Cancer Risk Assessment: A Step-Wise Approach for Primary Care Providers on the Front Lines of Shared Decision Making. Mayo Clin Proc. 2020;95(6):1268\u201375.","journal-title":"Mayo Clin Proc."},{"issue":"8","key":"8925_CR24","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1038\/s41436-018-0406-9","volume":"21","author":"A Lee","year":"2019","unstructured":"Lee A, Mavaddat N, Wilcox AN, Cunningham AP, Carver T, Hartley S, et al. BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. Genet Med. 2019;21(8):1708\u201318. https:\/\/doi.org\/10.1038\/s41436-018-0406-9.","journal-title":"Genet Med"},{"issue":"12","key":"8925_CR25","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1002\/cncr.32815","volume":"126","author":"T Mukama","year":"2020","unstructured":"Mukama T, Kharazmi E, Sundquist K, Sundquist J, Brenner H, Fallah M. Familial risk of breast cancer by dynamic, accumulative, and static definitions of family history. Cancer. 2020;126(12):2837\u201348. https:\/\/doi.org\/10.1002\/cncr.32815.","journal-title":"Cancer."},{"issue":"4","key":"8925_CR26","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.ejca.2009.11.016","volume":"46","author":"A Brandt","year":"2010","unstructured":"Brandt A, Bermejo JL, Sundquist J, Hemminki K. Familial risks of breast and prostate cancers: does the definition of the at risk period matter? Eur J Cancer. 2010;46(4):752\u20137. https:\/\/doi.org\/10.1016\/j.ejca.2009.11.016.","journal-title":"Eur J Cancer"},{"key":"8925_CR27","doi-asserted-by":"crossref","unstructured":"Frank C. Population landscape of familial Cancer. Doctoral dissertation. Heidelberg University; 2016.","DOI":"10.1038\/srep12891"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08925-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08925-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08925-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T01:31:55Z","timestamp":1726104715000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08925-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,12]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8925"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08925-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,12]]},"assertion":[{"value":"21 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We secured ethical approval and waiver of informed consent (February 6, 2013) for this study from the Regional Ethical Review Board of Lund University (Dnr 2012\/795). Patient consent was not required as the study used only de-identified registry based secondary data. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1210"}}